AstraZeneca receives the nod from the Indian regulator to launch the cancer drug Imfinzi

AstraZeneca receives approval to market Durvalumab solution for infusion, used in the treatment of cancer for an additional indication (Source/Unsplash) 1 minute read Last updated: February 10, 2026 | 2:40 PM IS AstraZeneca Pharma India Ltd said on Tuesday it has received approval from India’s drug regulator to commercialize Durvalumab solution for infusion used in […]